These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 41025

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Interaction between anti-aggregating and anticoagulant agents. A double blind study on the concomitant administration of nicergoline and acenocoumarols].
    Pogliani E, Recalcati P, Tantalo V, Bregnani P.
    Arzneimittelforschung; 1979; 29(8a):1266-9. PubMed ID: 395954
    [Abstract] [Full Text] [Related]

  • 23. [Use of nicergoline (IDB-1076) in the treatment of mild to moderate systemic arterial hypertension in adults and in the aged].
    Rinaldi G, Nieri A, Saponati G.
    Minerva Cardioangiol; 1987 Oct; 35(10):573-83. PubMed ID: 3438004
    [No Abstract] [Full Text] [Related]

  • 24. [Venous perfusion with nicergoline in the treatment of sudden deafness].
    Gratacap B.
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1982 Jan; 31(1):65-7. PubMed ID: 6210759
    [No Abstract] [Full Text] [Related]

  • 25. [Sermion treatment of middle-aged and elderly patients with initial atherosclerotic encephalopathy].
    Man'kovskiĭ NB, Mints AIa, Bachinskaia NIu, Kochubeĭ NV.
    Vrach Delo; 1989 Apr; (4):60-3. PubMed ID: 2756691
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of arterial hypertension in the elderly with an alpha-blocker: nicergoline (author's transl)].
    Forette F, Varin D, Henry JF, Hervy MP.
    Nouv Presse Med; 1980 Dec 20; 9(48):3685-8. PubMed ID: 7005872
    [Abstract] [Full Text] [Related]

  • 27. [Value of nicergoline in the prevention of postoperative thrombophlebitis].
    Kauffmann JP, Keller D, Calderoli H, Ackermann E, Hollender LF.
    Med Chir Dig; 1981 Dec 20; 10(2):169-72. PubMed ID: 7230952
    [No Abstract] [Full Text] [Related]

  • 28. [Nicergoline and severe isolated cranial injuries].
    Alibert F, Devaux C, Sauger F, Winckler C.
    Agressologie; 1982 Dec 20; 23(E):93-8. PubMed ID: 7137483
    [No Abstract] [Full Text] [Related]

  • 29. [Therapeutic potential and possibilities of using of sermion (nicergoline) in neurological practice].
    Damulin IV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010 Dec 20; 110(12):119-22. PubMed ID: 21434467
    [No Abstract] [Full Text] [Related]

  • 30. [Electroencephalographic study during long-term use of nicergoline].
    Miletto D, Julou M.
    Ann Med Psychol (Paris); 1976 Dec 20; 134(5):824-31. PubMed ID: 1026140
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical experience with Adetphos Kowa tablets in hearing disorders of labyrinthine origin].
    Kikuchi K, Sato H.
    Jibiinkoka; 1967 Nov 20; 39(11):1231-4. PubMed ID: 5627796
    [No Abstract] [Full Text] [Related]

  • 32. [Importance of improving sympathetic tonus in the medical treatment of impotence with vascular disorders: clinical and ultrasonic study of the action of nicergoline].
    Chomant J, de Somer-Leroy R, Boismare F, Boquet J, Ozenne G, Schrub JC.
    LARC Med; 1982 Sep 20; 2(8):717-9. PubMed ID: 7162273
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Drug therapy of lesions of the auditory organs and equilibrium].
    Kubichkova Ia, Kachorovski Z, Gervatov V, Iaskovski A.
    Vestn Otorinolaringol; 1988 Sep 20; (5):63-5. PubMed ID: 3227595
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical trial of a new vasoactive drug F.I. 6714 administered intra-arterially in peripheral vascular diseases].
    Masini G.
    Minerva Cardioangiol; 1975 Feb 20; 23(2):120-5. PubMed ID: 1095956
    [No Abstract] [Full Text] [Related]

  • 36. [Indications of Surheme in otorhinolaryngology. Clinical, audiometric and electronystagmographic study].
    Bertoni R.
    Therapeutique; 1971 Nov 20; 47(9):789-96. PubMed ID: 5147558
    [No Abstract] [Full Text] [Related]

  • 37. [Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
    Kugler JE, Meurer-Krüll BC.
    Arzneimittelforschung; 1985 Nov 20; 35(12):1865-70. PubMed ID: 3913425
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Therapeutic efficacy of nicergoline in ophthalmology. Fluorescence retinographic study (author's transl)].
    Borgioli M, Merendino E, Ricci B.
    Arzneimittelforschung; 1979 Nov 20; 29(8a):1311-6. PubMed ID: 540076
    [Abstract] [Full Text] [Related]

  • 40. [Clinical and rheographic results of nicergoline in the treatment of arteritis of the lower extremities].
    Schrub JC, Courtois H, Philippe JC, Boismare F.
    Therapie; 1975 Nov 20; 30(3):407-15. PubMed ID: 1224362
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.